Search

everythinglearnresearchcommunity

for

Search:↓

Individualized treatment and psychological support improved the patient's quality of life and appearance despite medication side effects.

People with ankylosing spondylitis in Taiwan don't have a higher chance of getting alopecia.

Self-monitoring blood pressure in pregnant women didn't improve outcomes, diabetes drugs may increase gallbladder disease risk, a new drug helps severe hair loss, a plant-based COVID-19 vaccine is 69.5% effective, and new anticoagulants are safer for diabetics with heart rhythm issues than warfarin.

5α-reductase inhibitors do not improve survival in oesophageal and gastric cancer patients.

Non-blinded assessors tend to overestimate effects in trials by about 29%.

Diabetes may lower the risk of prostate cancer.

Dutasteride and finasteride have equal safety for treating BPH without increased heart risk.

People with alopecia areata often have other health issues like skin diseases, metabolic syndrome, stomach infections, lupus, anemia, thyroid problems, mental health issues, vitamin D deficiency, and hearing and eye problems.

Hair loss links to higher death risk from diabetes and heart disease; not a direct cause, but a marker for risk factors.

Finasteride for hair loss increases risk of long-lasting sexual dysfunction.

Intramuscular corticosteroids are effective and safe for severe alopecia areata, with most patients regrowing hair, but nearly half may relapse.

Dutasteride and minoxidil mesotherapy effectively treats hair loss with minimal side effects.

Finasteride and dutasteride have little effect on Type 2 Diabetes risk.

Men with melanoma have a higher risk of later being diagnosed with prostate cancer.

Black ethnicity, prior PSA tests, enlarged prostate, and family history increase prostate cancer risk; Asian ethnicity, obesity, smoking, diabetes, and less sexual activity or no children decrease risk.

Higher BMI is linked to a lower risk of non-aggressive prostate cancer and a higher risk of aggressive prostate cancer.

Long-term diabetes is linked to lower prostate cancer risk.

Urinary stone cases in Wuwei City increased significantly from 1995 to 2016.

Higher fluoride levels may delay puberty in boys.

Male-pattern baldness is weakly linked to some heart disease risk factors but not a strong indicator for heart disease.

Dutasteride and finasteride have similar risk for osteoporosis and fractures in older men.

Bupropion causes more hair loss than other antidepressants, with paroxetine causing the least.

Finasteride might lower the risk of low-grade prostate cancer but not high-grade cancer, while alpha-blockers might reduce high-grade cancer risk.

Pegylated liposomal doxorubicin is as effective as conventional doxorubicin but causes fewer heart problems and side effects.

PrEP for HIV is less effective in transgender women mainly due to low adherence to the treatment.

People with Major Depressive Disorder have a higher chance of getting Alopecia Areata, and vice versa; antidepressants may lower this risk.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

Late puberty may slightly lower prostate cancer risk, baldness is not linked to overall risk but less so with aggressive types, ibuprofen use may increase risk, and vitamins show no effect on risk.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Men with baldness are more prone to skin cancers on the scalp due to sun exposure, not testosterone.